NEWS
Drug developer rattles tin for another cash dollop
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on ... read more
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on ... read more